本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tyra Biosciences, Inc.

18.74
-0.8600-4.39%
成交量:17.63万
成交额:335.01万
市值:12.88亿
市盈率:-7.80
高:19.60
开:19.39
低:18.68
收:19.60
52周最高:40.65
52周最低:13.35
股本:6,875.59万
流通股本:4,000.56万
量比:0.33
换手率:0.44%
股息:- -
股息率:- -
每股收益(TTM):-2.4031
每股收益(LYR):-2.0125
净资产收益率:-45.31%
总资产收益率:-28.46%
市净率:3.64
市盈率(LYR):-9.31

数据加载中...

2026/04/24

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

重要事件披露

Form 8-K - Current report
2025/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities